SQZ Biotechnologies Co
DelistedCIK 1604477fmd_06QTBQ3PWAKHJN1271XFGJ1T1QManufacturing · Biological Products, (No Diagnostic Substances)Template: Standard
Coverage: Jan 01, 2019 to Sep 30, 2023, 17 periods
| Line item | FY2019 | FY2020 | FY2021 | FY2022 |
|---|---|---|---|---|
| Total revenues | 20 | 21 | 27 | 21 |
| Research and development | 36 | 52 | 70 | 71 |
| Selling, general and administrative | 18 | 21 | 26 | 26 |
| Total operating expenses | 54 | 72 | 96 | 102 |
| Operating income | (34) | (51) | (69) | (81) |
| Interest and investment income | 2 | 1 | 0 | 1 |
| Other non-operating income (expense) | 2 | 1 | 0 | 1 |
| Income tax expense | 0 | 0 | 0 | 0 |
| Net income from continuing operations | 32 | 51 | 69 | 80 |
| Net income | (32) | (51) | (69) | (79) |